Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (387)
- Scheduling (national classification system) (168)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
768 result(s) found, displaying 576 to 600
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACMS#18, July 2016 (interim decision)
-
Corporate reportsThe TGA has published its Self-Assessment Report for 2016-17
-
-
Scheduling submissionsPublic submissions on matters referred to the July 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Scheduling submissionsPublic submissions on interim scheduling decisions for substances referred to the November 2017 ACMS/ACCS meetings are now available
-
Scheduling decisions (final)Final decisions for substances referred to the ACMS, ACCS/ACMS, ACCS November 2017 meetings, and delegate only decisions on agricultural and veterinary chemicals and NCEs.
-
Corporate reportsReport detailing prescription medicines registrations for 2017
-
Corporate reportsNew generic medicines and biosimilar medicines registered in 2017
-
Corporate reportsA step-by-step guide for prescription medicines
-
Meeting statementsACM 6 meeting statement has been published
-
Meeting statementsACM 7 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling submissionsPublic submissions on matters referred to the March 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Meeting statementsACM 5 meeting statement has been published
-
Meeting statementsACM 2 meeting statement has been published
-
Meeting statementsACM 3 meeting statement has been published
-
Meeting statementsACM 4 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting summary.
-
Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2018 -
Scheduling decisions (final)Scheduling delegates' final decisions: NCEs, January 2017 now published
-
Meeting statementsACV 1 meeting statement has been published
-
Meeting statementsACV 2 meeting statement has been published
-
Corporate reportsThis document reflects the evidence supporting the use of medicinal cannabis in treating chronic pain and the recommendations of the Chronic Pain Working Group